Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
Human Brain Mapping · 15.04.2023 · 44 (6) · 2395-2406
DOI: 10.1002/hbm.26217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 30.01.2023. Verfasst von Brandon Taraku und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: White Matter, Ketamine, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, National Institute of Mental Health.
Themen: Depression
Abstract (Originalsprache)
Ketamine produces fast‐acting antidepressant effects in treatment resistant depression (TRD). Though prior studies report ketamine‐related changes in brain activity in TRD, understanding of ketamine's effect on white matter (WM) microstructure remains limited. We thus sought to examine WM neuroplasticity and associated clinical improvements following serial ketamine infusion (SKI) in TRD. TRD patients ( N = 57, 49.12% female, mean age: 39.9) received four intravenous ketamine infusions (0.5 mg/kg) 2–3 days apart. Diffusion‐weighted scans and clinical assessments (Hamilton Depression Rating Scale [HDRS‐17]; Snaith Hamilton Pleasure Scale [SHAPS]) were collected at baseline and 24‐h after SKI. WM measures including the neurite density index (NDI) and orientation dispersion index (ODI) from the neurite orientation dispersion and density imaging (NODDI) model, and fractional anisotropy (FA) from the diffusion tensor model were compared voxelwise pre‐ to post‐SKI after using Tract‐Based Spatial Statistics workflows to align WM tracts across subjects/time. Correlations between change in WM metrics and clinical measures were subsequently assessed. Following SKI, patients showed significant improvements in HDRS‐17 ( p ‐value = 1.8 E‐17) and SHAPS ( p ‐value = 1.97 E‐10). NDI significantly decreased in occipitotemporal WM pathways ( p < .05, FWER/TFCE corrected). ΔSHAPS significantly correlated with ΔNDI in the left internal capsule and left superior longitudinal fasciculus ( r = −0.614, p ‐value = 6.24E‐09). No significant changes in ODI or FA were observed. SKI leads to significant changes in the microstructural features of neurites within occipitotemporal tracts, and changes in neurite density within tracts connecting the basal ganglia, thalamus, and cortex relate to improvements in anhedonia. NODDI may be more sensitive for detecting ketamine‐induced WM changes than DTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of California Los Angeles, Los Angeles, California, USA.
- Department of Psychiatry and Behavioral Sciences, University of California Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Brandon Taraku, Mayank Jog
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Taraku, B., Woods, R. P., Boucher, M., Espinoza, R., Jog, M., Al-Sharif, N., Narr, K. L., & Zavaliangos-Petropulu, A. (2023). Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression. Human Brain Mapping, 44(6), 2395-2406. https://doi.org/10.1002/hbm.26217
Vancouver
Taraku B, Woods RP, Boucher M, Espinoza R, Jog M, Al-Sharif N, et al. Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression. Human Brain Mapping. 2023;44(6):2395-2406. doi:10.1002/hbm.26217
BibTeX
@article{Taraku2023,
author = {Taraku, Brandon and Woods, Roger P and Boucher, Michael and Espinoza, Randall and Jog, Mayank and Al-Sharif, Noor and Narr, Katherine L and Zavaliangos-Petropulu, Artemis},
title = {Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression},
journal = {Human Brain Mapping},
year = {2023},
volume = {44},
number = {6},
pages = {2395--2406},
doi = {10.1002/hbm.26217}
}
EUVIMED